Brief: Jcr Pharmaceuticals Presents Preclinical Gene Therapy Research At The European Society Of Gene And Cell Therapy 31St Annual Congress
23/10/2024 13:33
Oct 23 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T :
* JCR PHARMACEUTICALS PRESENTS PRECLINICAL GENE THERAPY
RESEARCH
AT THE EUROPEAN SOCIETY OF GENE AND CELL THERAPY 31ST ANNUAL
CONGRESS
Source text for Eikon: ID:nBw4Ndjxna
Further company coverage: 4552.T
((Reuters.Briefs@thomsonreuters.com))
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results